UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Bax/Bcl-2 Ratio Determines the Susceptibility of Human Melanoma Cells to CD95/Fas-Mediated Apoptosis

Journal of investigative dermatology, 2001-08, Vol.117 (2), p.333-340

2001

Volltextzugriff (PDF)

Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2239-2245

2010

Volltextzugriff (PDF)

Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors

Clinical cancer research, 2008-11, Vol.14 (22), p.7378-7384

2008

Volltextzugriff (PDF)

Analysis of the p53/BAX Pathway in Colorectal Cancer: Low BAX Is a Negative Prognostic Factor in Patients With Resected Liver Metastases

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1364-1374

1999

Volltextzugriff (PDF)

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy

BMC cancer, 2006-05, Vol.6 (1), p.124-124, Article 124

2006

Volltextzugriff (PDF)

Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies

Oral oncology, 2008-09, Vol.44 (9), p.857-869

2008

Volltextzugriff (PDF)

Effect of dance on cancer-related fatigue and quality of life

Supportive care in cancer, 2014-08, Vol.22 (8), p.2241-2249

2014

Volltextzugriff (PDF)

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis

BMC cancer, 2005-08, Vol.5 (1), p.105-105, Article 105

2005

Volltextzugriff (PDF)

Population pharmacokinetic model for regorafenib: A meta-analysis

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e13580-e13580

2015

Volltextzugriff (PDF)

A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

International journal of cancer, 2019-11, Vol.145 (9), p.2450-2458

2019

Volltextzugriff (PDF)

Abstract CT148: A phase Ib study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT148-CT148

2016

Volltextzugriff (PDF)

227 Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study

Cancer biotherapy & radiopharmaceuticals, 2021-10, Vol.36 (8), p.672-681

2021

Volltextzugriff (PDF)

Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report

Journal of medical case reports, 2008-08, Vol.2 (1), p.275-275, Article 275

2008

Volltextzugriff (PDF)

Assessment of communication about palliative care between physicians and their patients with cancer prior to admission to the palliative care unit (PCU)

Journal of clinical oncology, 2013-11, Vol.31 (31_suppl), p.18-18

2013

Volltextzugriff (PDF)

Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancers

Clinical lung cancer, 2015-11, Vol.16 (6), p.514-522

2015

Volltextzugriff (PDF)

Assessment of communication about palliative care between physicians and their cancer patients prior to admission to the palliative care unit (PCU)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20575-e20575

2013

Volltextzugriff (PDF)

Dynamic Expression Profile of p21WAF1/CIP1 and Ki-67 Predicts Survival in Rectal Carcinoma Treated With Preoperative Radiochemotherapy

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3391-3401

2003

Volltextzugriff (PDF)

Thrombocytopenia as first manifestation of splenic angiosarcoma

Annals of hematology, 2010-01, Vol.89 (1), p.109-110

2010

Volltextzugriff (PDF)

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

Clinical lung cancer, 2015-04, Vol.16 (6), p.514-522

2015

Volltextzugriff (PDF)

Lenalidomide, Adriamycin and Dexamethasone (RAD) As An Induction Regimen In Newly Diagnosed Multiple Myeloma – Interim Results From a German Multicenter Phase II Trial

Blood, 2013-11, Vol.122 (21), p.1987-1987

2013

Volltextzugriff (PDF)

Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers

Clinical lymphoma, myeloma and leukemia, 2012-06, Vol.12 (3), p.191-196

2012

Volltextzugriff (PDF)

Analysis of p53/BAX/p16ink4a/CDKN2 in Esophageal Squamous Cell Carcinoma: High BAX and p16ink4a/CDKN2 Identifies Patients With Good Prognosis

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2272-2281

2001

Volltextzugriff (PDF)

Large paraganglioma of the abdominal cavity: a case report and review of the literature

Onkologie, 2010-01, Vol.33 (7), p.377-380

2010

Volltextzugriff (PDF)

Sickle cell disease, pulmonary hypertension, and sarcoidosis

Annals of hematology, 2008-07, Vol.87 (7), p.591-592

2008

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(51)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Bax/Bcl-2 Ratio Determines the Susceptibility of Human Melanoma Cells to CD95/Fas-Mediated Apoptosis

Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial

Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors

Analysis of the p53/BAX Pathway in Colorectal Cancer: Low BAX Is a Negative Prognostic Factor in Patients With Resected Liver Metastases

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy

Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies

Effect of dance on cancer-related fatigue and quality of life

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis

Population pharmacokinetic model for regorafenib: A meta-analysis

A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

Abstract CT148: A phase Ib study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

227 Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study

Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report

Assessment of communication about palliative care between physicians and their patients with cancer prior to admission to the palliative care unit (PCU)

Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancers

Assessment of communication about palliative care between physicians and their cancer patients prior to admission to the palliative care unit (PCU)

Dynamic Expression Profile of p21WAF1/CIP1 and Ki-67 Predicts Survival in Rectal Carcinoma Treated With Preoperative Radiochemotherapy

Thrombocytopenia as first manifestation of splenic angiosarcoma

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

Lenalidomide, Adriamycin and Dexamethasone (RAD) As An Induction Regimen In Newly Diagnosed Multiple Myeloma – Interim Results From a German Multicenter Phase II Trial

Response to Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Newly Diagnosed Multiple Myeloma Is Independent of Cytogenetic Risk and Retained after Double Stem Cell Transplant

Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers

Analysis of p53/BAX/p16ink4a/CDKN2 in Esophageal Squamous Cell Carcinoma: High BAX and p16ink4a/CDKN2 Identifies Patients With Good Prognosis

Large paraganglioma of the abdominal cavity: a case report and review of the literature

Sickle cell disease, pulmonary hypertension, and sarcoidosis

Suchergebnisse filtern